Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate (Q60976770)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 2004

Language	Label	Description	Also known as
English	Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate	scientific article published on 01 December 2004

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

Angela Dispenzieri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

11

object named as

Litzow MR

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

object named as

Gertz MA

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

object named as

Lacy MQ

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

10

object named as

Tefferi A

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Ansell SM

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Elliott MA

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Gastineau DA

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Inwards DJ

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Micallef IN

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Porrata LF

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1025-1031

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15516945%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704691

0 references

Biological features of the clone involved in primary amyloidosis (AL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation for primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for staining amyloid in tissues: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum test for assessment of patients with Bence Jones myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Using weighted Kaplan-Meier statistics in nonparametric comparisons of paired censored survival outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of "primary" renal amyloidosis with melphalan.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell transplantation for the management of primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma treated with high dose intravenous melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta 2-microglobulin predicts survival in primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704691

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60976770&oldid=1948262232"